Walgreens Boots Alliance will sell its pharmacy wholesale unit to AmerisourceBergen. Walgreens says it plans to focus on its retail pharmacies and its health initiatives, in the face of rising competition from Amazon and CVS. (The Wall Street Journal)
The Centers for Disease Control and Prevention said the rate of allergic reactions to COVID-19 vaccines is 11.1 per one million vaccinations. Health officials continue to emphasize that severe reactions are “exceedingly rare” and urge people to get vaccinated. (Reuters)
CRISPR gene editing successfully helped mice with progeria live longer, a new study published on Wednesday found. The results point to potential treatments for progeria and other genetic diseases. (STAT)
The Food and Drug Administration granted priority review to AstraZeneca’s SGLT2 inhibitor Farxiga for chronic kidney disease. Farxiga was originally approved by the FDA in 2014 for treatment of type 2 diabetes. (Endpoints News)
Operation Warp Speed chief scientific officer adviser Moncef Slaoui said he will stay on as a consultant for the Biden administration. Slaoui had previously said he would step down early this year. (POLITICO)
